{"ticker": {"uuid": "9979b2ef-40f1-4528-9c1d-af07dc7e5358", "symbol": "PPLPHARMA", "name": "Piramal Pharma Limited", "exchange": "NSI", "country": "IN", "sector": "Healthcare", "industry": "Drug Manufacturers - Specialty & Generic"}, "articles": [{"title": "Piramal Pharma shares rise 4% on successful closure of US FDA inspection", "summary": "", "url": "https://news.google.com/rss/articles/CBMi-AFBVV95cUxOV0xqSjdiNlNhRm4wak5hNTRzaExvYlItZm5jcUlFRUdBZFZJUFpfVUtrZEFiMGprZERwWmthLVh2VnV2Y1hDLXoyRWFnc0dPWUZ2VHBZSlhfRkJsUWdnRUNwTUd4RkQ5bzIwWnhnbnFMLVNmSUpFUUxkLTRLVFpEV0RISzNvTFJOcjVBbFFPS2xVR3Q1Xy0wdHEzZFVLS2NRRGNlN0R4dUxoUUZOM1JPQkQ2cUZlN3otcmU5cml0VG9QSmEyNVFwcWxCNTV5TGhZcUZTdlNOb0c2QnJONHZJTnhwQ05TUnRoMFkwTGRqQm5LVUpkZFYzVdIB_gFBVV95cUxOaWhrSlhTeUhmOVdYdWRTVFMydnpmY0pyY1psRFFOeEZKSEQyNTROSXZNQXFaX2pkZkZUc0FVRWMyZUNxdnNWNDBjTUxPVU9sREg5N25nd0VacmR5YkpOX01xLURhcWlET1p4Wm9iNEVoa2RYbVRSMHItaUFYa080ajRuaUZ3LWhlX3dLZ2ZsY1RsenNzUGRsaDY1VS1JM192MFJlQUtlQnBoUzJzM0FDY2dXckpWQU5LbHBWaG1OWC1KcnJYY0Q3R0JOOEZKdVB6VXhQR1M2SlltdGk5X0VVTWtsdldDNExjT1g0dkJzODlwbkg0Y29zOUJyWGRhQQ?oc=5", "source_name": "Business Standard", "published_at": "2026-07-09T09:46:48+00:00", "published_display": "09 Jul 2026 09:46", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Stocks to buy: Piramal Pharma, HSCL among 3 top bets by Choice Broking", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "Business Standard", "published_at": "2026-07-06T07:00:00+00:00", "published_display": "06 Jul 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Piramal Pharma promoters declare no share encumbrance in FY26", "summary": "", "url": "https://news.google.com/rss/articles/CBMiugFBVV95cUxPLVNhZkpmMnkwXzlXQWtoaC1YeEw4OWc1NzY4U2RqUmZUOWtnTl9FZE1YZHMxWEFxVFJXWVJja2ZOaW1EWnpHWmw3UXlXd1FLV3NhQmN1SW13TElWTVBQNEFCc00zY1lyRFQyNjRDUXdvZzBlQUxLcGNkUmUyeVczbk02eXlTeE9LbERZclR6Rk1mRTZ1M3lRUmZjekZBUVhrSjM2aHpzRGs2eWw1a2JmN0NiNzFucUZJWmc?oc=5", "source_name": "scanx.trade", "published_at": "2026-06-29T07:00:00+00:00", "published_display": "29 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Nifty Pharma extends rally, up 2%; Piramal Pharma, Laurus gain up to 10%", "summary": "", "url": "https://news.google.com/rss/articles/CBMizwFBVV95cUxQc2h2QThKS1RQOGlFekFQeVFjTWRzTThvendLUVRiVGYyR2NMdmdfSWhIeTk0WDdLMC1TTUxKWnFGLUg2N3pxVi1MWjR6WGVKRG9PZnladUlTN1BZUTE5NnlISkh2UXhVcnVjLVBIOFo3eEZyN2EyVkxFNWhXMlRjN1l0REhvN2k4alhQWFAyNWRvd0F6LUZFaXZPNTE2dVh6ZUxPeTFRV0JtMTlYalFQRWdZT0Z0OGRwUnZPdGRZRS1aOGNnSEdtTk1XZ190NG_SAdQBQVVfeXFMT3lDRnYwcnRsZ0wyNnVGLVdTYlR3anMxdDFZVFhXQS02UXJka1R4RDdxNVR5WENyYVRFM2lkOHhUTWhVOEhHWURzVV9jaXhlUDdqaHV2ckZaaUxUSXhiekRzWHhOZ0F3MzNnM2tkb1BOY2RfZDJjX2VQNVVWdm91ODY1X1NKY19FX05adGJ5aFhMMjVGcEVsR3lHdlJScndIWFBiT21GRmMzR0RlX3NJX1FrMkNwRktUWWgxZnBaUmtNZUwyN2ZCUnFWbExzQXNUNzhLUkY?oc=5", "source_name": "Business Standard", "published_at": "2026-06-23T07:00:00+00:00", "published_display": "23 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Piramal Pharma Share Price Spikes Over 10% \u2014 What Is Driving The Rally?", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "NDTV Profit", "published_at": "2026-06-23T07:00:00+00:00", "published_display": "23 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 58, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "PIRAMAL PHARMA Share Price Today Up 7%", "summary": "", "url": "https://news.google.com/rss/articles/CBMilgFBVV95cUxNS2V0MTNGa21EX28zU0gycGVCZ2lJOWp3eXV3SW9JOVRKejI1bHNlXzlzWFVMWDJySFNZR1RpR2k4VW5OT0VNZHNSMXEzNG9zV1Z1cVRSdmZqb3ZyUGpDbURsek9IRlNfa3hmYUk5U0pCZVhjSmIyLVJsMUFTOHl2ZWRZTkhLdGlLdk8zVjZpVnBvTGhZNHc?oc=5", "source_name": "Equitymaster", "published_at": "2026-06-23T07:00:00+00:00", "published_display": "23 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Piramal Pharma - Positive Breakout: These 11 stocks cross above their 200 DMAs", "summary": "", "url": "https://news.google.com/rss/articles/CBMi4AFBVV95cUxNb190R0NxNFZSeG5QWWF6VWpDMHM1NXUwVU9hazBMVkh6LTd4bEc5WndRdG43eUg2VkVtby1zUHg1V1BlQm5nMXJTbEZMYmgwcXE2c0tFTUJZaE4yOGJMdTAteENZbnlnY2ZwcjNpa1NKVlRidGxtNmlfQ2Q0N2dKX0tIYkNSUFZYT1Vyclg1c0xsRTBqdG54eWFQZjh2SmpIYUtJVjd0emZNVThHRjExSmFSTTVVQmVUUjYyb2JDV28yLXdiWnpNUlpjRDlpOFlFQWRQc1dhbzcxbFlfdi1FRg?oc=5", "source_name": "The Economic Times", "published_at": "2026-05-26T07:00:00+00:00", "published_display": "26 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Piramal Pharma Schedules Investor Meetings from 28 May", "summary": "", "url": "https://news.google.com/rss/articles/CBMi6AFBVV95cUxPQ1JjTk1uTVJRSEY3SGRvN25XWFUtLU5ocDBjOG9LTE50UWg3MUVHYkxYb2RrQkRDMHVDLTZhaDZ0UVdGVWdYckZqVkQwcl9NTnRvd2p4UGpLMnVsQkUxa3JWbVUxbUJwTjF5WU13cURNT21WY0dnbVJvc1BTajd3clNDVjlTbXNhWW5Ca1lfeU1iSGd4MVIzc20wM3hmaTdNU3JjMVpxNXlUZDZ1aElDS3BEUkRIanl3NTJGWGppRmdHbnpIQWhGU2F2djhMRUNPYlhfU29tWlAtUEJWZUU1RnZxZC1PcU1w?oc=5", "source_name": "scanx.trade", "published_at": "2026-05-19T07:00:00+00:00", "published_display": "19 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Piramal Pharma, Tanla & PTC India Surge in May After Being Picked by AI Strategy By Investing.com", "summary": "", "url": "https://news.google.com/rss/articles/CBMizwFBVV95cUxNUGU0UUoyYldKdzhRZHhlYkVaS0hfMHJkUmVaeEZOcjJNRkNoRXZheS1WdUdlUGFUd196VFR0N3B3UXBXTHMyZmhuN2dMWk9PNE1FM3ZBNUlwRTA2Zl9hNjhJQTBxRkZ4S2RqS1VYdEk2aXN2Y1RGYVRvenBNMXFjbG1WS1JWSERRb0o1eVd0WUNUY1dPb2prdE1TcUREY01hTjc5Rl9jQ2hLdXoyOW1wOC1zNWk0dUs5TmpMR1l1Z2FQZ25lV3VuWEpyNmxhdnc?oc=5", "source_name": "Investing.com India", "published_at": "2026-05-08T07:00:00+00:00", "published_display": "08 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Piramal Pharma Limited Announces Schedule of Analyst/Institutional Investor Meeting for May 27, 2026", "summary": "", "url": "https://news.google.com/rss/articles/CBMi1gFBVV95cUxNUkVSOEc5S1c3c2VvQVlvNnRpZDBDQ2g1NEI5WVc4WDdoSmVCSjRRZlEtN0dRbVNtYUVrYV9GdUswRUJYMDZjT0kzUDNrSjN0LUFxeldWTExaaXQydUp1RmJ6SktqeWo3OWRmaW8tN0lSLUU3UWNJOTlMTXlDcXhkSDBKaW5yTEdETXUwSFlqeG4tVUdFTVdKZDY1c194bGFfRHctR3Y0cGNvSFdCekp4Q04zUnRGemlGMW1rRnZCenA5Q2pRZmFZWXAxQVRuSlFLSWVZQ1JB?oc=5", "source_name": "scanx.trade", "published_at": "2026-05-04T07:00:00+00:00", "published_display": "04 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Nifty Pharma index rises 2.5% on strong growth prospects; Dr Reddy's, Piramal Pharma jump up to 11%", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "Moneycontrol.com", "published_at": "2026-04-23T07:00:00+00:00", "published_display": "23 Apr 2026 07:00", "sentiment": "positive", "sentiment_pct": 82, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Nifty Pharma index soars 3%; Dr Reddy's, Piramal Pharma rally up to 9%", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "Business Standard", "published_at": "2026-04-23T07:00:00+00:00", "published_display": "23 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Piramal Pharma Schedules Board Meeting and Earnings Call for Q4FY26 Results", "summary": "", "url": "https://news.google.com/rss/articles/CBMi7gFBVV95cUxNZkpBbnJWMVlRVjI5QTBBOTlVMTB5cWZDVkFoNXlaNEZqX0JMV3JVODVJcnlJaDY4bHlPN1JWZEdCdEtMOXRhUS1yekNjYzlRRnNLS194SzdVMlBjS3RfQ0dsR2NiTllEYTNLRkFUellndERJU3RJVTUyWVM2STgyRzJSdTR2djBUcVRjSGhhZnJtTnBUUHFHNlpKUWEwV0dzeV8yOHZlUWo0c0FWVWxyYnlJMlcxdG5pS3RITUhSTmpOTktUQ3Y0aEpIWGpiSE5IMWxWcm5xWFZkemhSVVgyMWZHaWxtZU9HWERtcXhB?oc=5", "source_name": "scanx.trade", "published_at": "2026-04-17T07:00:00+00:00", "published_display": "17 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Piramal Pharma Ltd spurts 2.13%, rises for third straight session", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "Business Standard", "published_at": "2026-04-15T07:00:00+00:00", "published_display": "15 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Trump tariffs hit patented drugs: Jefferies, Nomura explain impact on pharma stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMi7AFBVV95cUxOOURreGN5eDNZSERyb0tadW9lUnVMbk5yb01OZ3Q0WHBOLTVrRVVzRnNraWhzNVZmV0lRc0VmT3V1aHVsNFVPUDRnWl9MR2ZFSTFMS09KNW9BUzJwZ0ZvUUZxU1FXMnJZYWtHcmV1ZnpRa3ZXamNQZXhxalN4TTZoQ25nekFFM0lERnp3MkE4UVVjZzBMWTJuY01KcFpKWURnaUJoNV80dmlvVUNFQmc3THhjTG5Zbmt4VGc4MXlxVWxBbF9BQ1pSZ1Q0bnlyak5SSUFQWVNTUFdyUnJBNmVDVVpGY1JKTlNfRnBjbg?oc=5", "source_name": "ETPharma.com", "published_at": "2026-04-07T07:00:00+00:00", "published_display": "07 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Lupin, Biocon: Nifty Pharma gains 3% after US-India trade deal pact", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "Business Standard", "published_at": "2026-02-03T08:00:00+00:00", "published_display": "03 Feb 2026 08:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Piramal Pharma Limited (NSE:PPLPHARMA) Just Reported Earnings, And Analysts Cut Their Target Price", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-01-31T08:00:00+00:00", "published_display": "31 Jan 2026 08:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Piramal Pharma Releases Q3FY26 Earnings Call Transcript Following Results Discussion", "summary": "", "url": "https://news.google.com/rss/articles/CBMi3gFBVV95cUxQRlRCUzBxR0lFMDNCa3B3OFRHQW5LNVp6Mk5zMGlMa05mdWFWVm52MmgtLUN4ZmlPaDF0clRSeXNiUldXSmQ1b0hUMER5WVVONG54Z1R5eGRHenpMN1BNRUFOcHI2NVBIYjZLTEU2UnNGajlUMzQwVS1KREdQVzVuNG9LOHRsazVOMmdlV0cwTmF5QTBxMnhKU0xQcFRUSUljN3R1VXF4VFFZc0hGemZtbDA0QUk2bzhzdlItOXI0Nnd6OE1KczhxcVZjX1RBVWRHY3RaOERKNHM2YW5YbVE?oc=5", "source_name": "scanx.trade", "published_at": "2026-01-30T08:00:00+00:00", "published_display": "30 Jan 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Piramal Pharma shares gain 4% on Q3 results; check key highlights inside", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "Business Standard", "published_at": "2026-01-29T08:00:00+00:00", "published_display": "29 Jan 2026 08:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Buy, Sell or Hold: Piramal Pharma Ltd, Kaynes Technology India Ltd, Electronics Mart \u2014 Ask Profit", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "NDTV Profit", "published_at": "2026-01-22T08:00:00+00:00", "published_display": "22 Jan 2026 08:00", "sentiment": "positive", "sentiment_pct": 74, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Piramal Pharma (NSE:PPLPHARMA) Takes On Some Risk With Its Use Of Debt", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-01-15T08:00:00+00:00", "published_display": "15 Jan 2026 08:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Piramal Pharma Ltd. Share Price Today - Piramal Pharma Ltd. Stock Price Live NSE/BSE", "summary": "", "url": "https://news.google.com/rss/articles/CBMigAFBVV95cUxOUXVHS3NYLWU4b2ZzYU1XMlNlbFpmd0xfMHFfU1hBRDFsVjZObjFUb0xCc0wzejRTd2RoSV84M1RxLVFpYlRVcXJRMEo5LTRMTUo1dnhTOFd2anJsZDFGZVFXdGQ5UHoxdHNOUWR6SXpBUHZ2djJfZkd1bmVya0Y5Nw?oc=5", "source_name": "CNBC TV18", "published_at": "2026-01-03T16:33:11+00:00", "published_display": "03 Jan 2026 16:33", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Stocks to Watch Today: Vedanta, Piramal Pharma, NBCC, Cyient, Honasa Consumer, Kansai Nerolac,...", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "Moneycontrol.com", "published_at": "2025-12-12T08:00:00+00:00", "published_display": "12 Dec 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Corner Office Conversation: Nandini Piramal of Piramal Pharma & Arjun Juneja of Mankind Pharma", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "The Economic Times", "published_at": "2025-11-24T08:00:00+00:00", "published_display": "24 Nov 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "The Price Is Right For Piramal Pharma Limited (NSE:PPLPHARMA)", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2025-11-06T08:00:00+00:00", "published_display": "06 Nov 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Piramal Pharma Q2 Loss \u20b999 Cr as Revenue Falls 9% YoY", "summary": "", "url": "https://news.google.com/rss/articles/CBMif0FVX3lxTE5JVUo4LTVNczVURjFoYmhQOWozanpXaXZjUUQzS2RLYVN1YTFRNWJ4NFVwNEtLRk9KVVJxeHFYTUhuMmQxTU54S1l4NHVkc0hIWlVyZ3YxV0tJTXJhNGR0RGxneDNFQzBER0hrOWVlYURDMFZacF90NS15WmdkMzQ?oc=5", "source_name": "HDFC Sky", "published_at": "2025-11-06T08:00:00+00:00", "published_display": "06 Nov 2025 08:00", "sentiment": "negative", "sentiment_pct": 18, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Piramal Pharma Reports 21% Revenue Decline in Q2FY26, Cites Customer Inventory Destocking", "summary": "", "url": "https://news.google.com/rss/articles/CBMi2wFBVV95cUxNeFVLVlBiMmhfZEhWVkJ5WFJLYnVaeHRIN0VGWkNnRGhhVVhUQ1ZHdW9ZcGJqTFBncU1pRHZLMXVwUWFCQ283bWowbnlMYjN5MHNxU1RPdDRpV1NNa1c4ZDFqc09kYUxNZThtNTNqLTdlUlZFWVhGanJHOVc1dHpYMzY3blhlSlhsaXlpT3Vkakg3WjJKbVV0dmdlcjd3ZmFHSlloakFsU3hrRHlDR1FoSlBnY1BVb0lsYXRvSzZ1T3hDbDg4d2swRGJRUFRxbEVyXy1HekRiRmdmNms?oc=5", "source_name": "scanx.trade", "published_at": "2025-11-05T08:00:00+00:00", "published_display": "05 Nov 2025 08:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Are Piramal Pharma Limited's (NSE:PPLPHARMA) Mixed Financials Driving The Negative Sentiment?", "summary": "", "url": "https://news.google.com/rss/articles/CBMi7gFBVV95cUxPZjJrR2RxMnVKcV9QRGQxV1piQXNMTlcyU3pZSmRtLVJfMjR0aFQxY0U0QWt2Z3hpMEZaM1E4Q05DbnVTbHJIUWN4NkJhanFrNEhpdHQ3TU13MGxXcUNWV0l6U0hlSnRrOFk2VTlQajJoVGptdDlqc0xsYjhWRU1ESTJxeWJYaWhCbF9yR3kyTXRKRnBLMWJ6WVYwMHNFd0pJWlVFQ1M2aG5Ia0pTaUg3SzFRNmJNdXg3UkR6Mm84YlRTS3d1TGxXWDlSVkdHOWNmRWxXRFJCOWl1QTU3am5OQlNaVUFMMWxXUFAyaEZn0gHzAUFVX3lxTFBDVkhUaXE3R09xRzU5OWR0OFZWV0o4RmRpMk9uMGRqLXRQRWdQVTgxYzlnYjE5RUNKVzV0WXRBak9WR0JqTXJDT2FUSC1oUkZvdlIyLWFzX255VjgxVVhMcGxOZFZTaTBMSjRwQ0lxaWNZTTRHMHhCaG1fY01ubi1SRDlUUUZ6bjJRZElkaTBNM0ZhYzNTc2tRSklodW1aUkNtV01EM2R5SHBqUk40M0R6Z0R5My14LXhuSW5NQjgyei1wWGlwc0U1OXY5c0xubjh6M0xLU3AxQ09iYkI4YUI4WVNtOElaaWZBTnRtb2tCRk45dw?oc=5", "source_name": "simplywall.st", "published_at": "2025-10-07T07:00:00+00:00", "published_display": "07 Oct 2025 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "InCred Equities sees 41% upside in Piramal Pharma; initiates 'Buy'", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "Business Standard", "published_at": "2025-09-26T07:00:00+00:00", "published_display": "26 Sep 2025 07:00", "sentiment": "positive", "sentiment_pct": 82, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Piramal Pharma Subsidiary Invests $190.3 Million in PPL Pharma Inc.", "summary": "", "url": "https://news.google.com/rss/articles/CBMiygFBVV95cUxPb0h5MnNHOUFoOWZwSzk2MzJITnBQTGpqcjFoaV9VbTh3eWI2YTlpWHNkN1M2ZDVlcWJ6aEVkUk5MSkFoVEI1WXpoemxlbldrTUU3X2F4M2R4blItUWpoS21VRzM5b0h0SUdkVmxzdzdDMUs1RXZVVko2OGFObTR3dV83Y0kxWTVwc3hNeURjX2FaSm9NWXA5UG5ELUF2TmZYOXVDazJ5VWVzbERvbl92cko1Q0xRdGtfSFpoQTFvQjFiTVpzWTE3WjBR?oc=5", "source_name": "scanx.trade", "published_at": "2025-08-20T07:00:00+00:00", "published_display": "20 Aug 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Piramal Pharma unit infuses \u20b91,626 crore into PPL Pharma via preference shares", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "CNBC TV18", "published_at": "2025-08-20T07:00:00+00:00", "published_display": "20 Aug 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Piramal Pharma Ltd Share Price Today \u2013 Live NSE/BSE", "summary": "", "url": "https://news.google.com/rss/articles/CBMib0FVX3lxTE5QdkNRaDdFNVcwcEhHSWMycjNxR3BfbkhOTzZGR2RJM2R6MU9Qb1RTckRuaWtJYVNNdDBaMUxlMndvLVVxYzhLcC1FSGd2ZlVjRnI2SVNheEM3MGFDNzVQOS1wZEs1QUc3UDljcVM2cw?oc=5", "source_name": "INDmoney", "published_at": "2023-02-23T21:59:50+00:00", "published_display": "23 Feb 2023 21:59", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Technical Analysis of Piramal Pharma Limited (NSE:PPLPHARMA)", "summary": "", "url": "https://news.google.com/rss/articles/CBMibkFVX3lxTE8xT1hFSVJ4VzJZaGJrUjhmU2NsUkttX1I4cWxPeHVacmdLUFRMdUlIaFlYVEZvUWJod0wtb2QxMlN3ZUVueFhvbUtHSktKQmgxQ0JPY0tZY0tFcFpiY0ZUNXdrR2I2RGRMS0I3dDVB?oc=5", "source_name": "TradingView", "published_at": "2022-10-19T19:28:39+00:00", "published_display": "19 Oct 2022 19:28", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Piramal Pharma Limited lists on BSE and NSE", "summary": "", "url": "https://news.google.com/rss/articles/CBMipAFBVV95cUxPVjRHbWVuUS11MkQxdkhlckh6Wk1QVmNNaktjdmMxVS1fc3BYQUtYdE0zYzRPeEdHS054VV9xVWhjc2swNHdna25BNlZNekxCZEI5V1NUYkptQzJBbGlScjJFUzZKQktDcnlOSERzclQwTl9KV0lKdzYyQmhGM2o1MXpxcGU5NUFxN1Z6eDZjcGdidjYtTmxwVE5ZUktmajhYbmVLYw?oc=5", "source_name": "PR Newswire", "published_at": "2022-10-19T07:00:00+00:00", "published_display": "19 Oct 2022 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Piramal Pharma shares rise 4% on successful closure of US FDA inspection", "summary": "", "url": "https://news.google.com/rss/articles/CBMi-AFBVV95cUxOV0xqSjdiNlNhRm4wak5hNTRzaExvYlItZm5jcUlFRUdBZFZJUFpfVUtrZEFiMGprZERwWmthLVh2VnV2Y1hDLXoyRWFnc0dPWUZ2VHBZSlhfRkJsUWdnRUNwTUd4RkQ5bzIwWnhnbnFMLVNmSUpFUUxkLTRLVFpEV0RISzNvTFJOcjVBbFFPS2xVR3Q1Xy0wdHEzZFVLS2NRRGNlN0R4dUxoUUZOM1JPQkQ2cUZlN3otcmU5cml0VG9QSmEyNVFwcWxCNTV5TGhZcUZTdlNOb0c2QnJONHZJTnhwQ05TUnRoMFkwTGRqQm5LVUpkZFYzVdIB_gFBVV95cUxOaWhrSlhTeUhmOVdYdWRTVFMydnpmY0pyY1psRFFOeEZKSEQyNTROSXZNQXFaX2pkZkZUc0FVRWMyZUNxdnNWNDBjTUxPVU9sREg5N25nd0VacmR5YkpOX01xLURhcWlET1p4Wm9iNEVoa2RYbVRSMHItaUFYa080ajRuaUZ3LWhlX3dLZ2ZsY1RsenNzUGRsaDY1VS1JM192MFJlQUtlQnBoUzJzM0FDY2dXckpWQU5LbHBWaG1OWC1KcnJYY0Q3R0JOOEZKdVB6VXhQR1M2SlltdGk5X0VVTWtsdldDNExjT1g0dkJzODlwbkg0Y29zOUJyWGRhQQ?oc=5", "source_name": "Business Standard", "published_at": "2026-07-09T09:46:48+00:00", "published_display": "09 Jul 2026 09:46", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Stocks to buy: Piramal Pharma, HSCL among 3 top bets by Choice Broking", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "Business Standard", "published_at": "2026-07-06T07:00:00+00:00", "published_display": "06 Jul 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Piramal Pharma promoters declare no share encumbrance in FY26", "summary": "", "url": "https://news.google.com/rss/articles/CBMiugFBVV95cUxPLVNhZkpmMnkwXzlXQWtoaC1YeEw4OWc1NzY4U2RqUmZUOWtnTl9FZE1YZHMxWEFxVFJXWVJja2ZOaW1EWnpHWmw3UXlXd1FLV3NhQmN1SW13TElWTVBQNEFCc00zY1lyRFQyNjRDUXdvZzBlQUxLcGNkUmUyeVczbk02eXlTeE9LbERZclR6Rk1mRTZ1M3lRUmZjekZBUVhrSjM2aHpzRGs2eWw1a2JmN0NiNzFucUZJWmc?oc=5", "source_name": "scanx.trade", "published_at": "2026-06-29T07:00:00+00:00", "published_display": "29 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Nifty Pharma extends rally, up 2%; Piramal Pharma, Laurus gain up to 10%", "summary": "", "url": "https://news.google.com/rss/articles/CBMizwFBVV95cUxQc2h2QThKS1RQOGlFekFQeVFjTWRzTThvendLUVRiVGYyR2NMdmdfSWhIeTk0WDdLMC1TTUxKWnFGLUg2N3pxVi1MWjR6WGVKRG9PZnladUlTN1BZUTE5NnlISkh2UXhVcnVjLVBIOFo3eEZyN2EyVkxFNWhXMlRjN1l0REhvN2k4alhQWFAyNWRvd0F6LUZFaXZPNTE2dVh6ZUxPeTFRV0JtMTlYalFQRWdZT0Z0OGRwUnZPdGRZRS1aOGNnSEdtTk1XZ190NG_SAdQBQVVfeXFMT3lDRnYwcnRsZ0wyNnVGLVdTYlR3anMxdDFZVFhXQS02UXJka1R4RDdxNVR5WENyYVRFM2lkOHhUTWhVOEhHWURzVV9jaXhlUDdqaHV2ckZaaUxUSXhiekRzWHhOZ0F3MzNnM2tkb1BOY2RfZDJjX2VQNVVWdm91ODY1X1NKY19FX05adGJ5aFhMMjVGcEVsR3lHdlJScndIWFBiT21GRmMzR0RlX3NJX1FrMkNwRktUWWgxZnBaUmtNZUwyN2ZCUnFWbExzQXNUNzhLUkY?oc=5", "source_name": "Business Standard", "published_at": "2026-06-23T07:00:00+00:00", "published_display": "23 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Piramal Pharma Share Price Spikes Over 10% \u2014 What Is Driving The Rally?", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "NDTV Profit", "published_at": "2026-06-23T07:00:00+00:00", "published_display": "23 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 58, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "PIRAMAL PHARMA Share Price Today Up 7%", "summary": "", "url": "https://news.google.com/rss/articles/CBMilgFBVV95cUxNS2V0MTNGa21EX28zU0gycGVCZ2lJOWp3eXV3SW9JOVRKejI1bHNlXzlzWFVMWDJySFNZR1RpR2k4VW5OT0VNZHNSMXEzNG9zV1Z1cVRSdmZqb3ZyUGpDbURsek9IRlNfa3hmYUk5U0pCZVhjSmIyLVJsMUFTOHl2ZWRZTkhLdGlLdk8zVjZpVnBvTGhZNHc?oc=5", "source_name": "Equitymaster", "published_at": "2026-06-23T07:00:00+00:00", "published_display": "23 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Piramal Pharma - Positive Breakout: These 11 stocks cross above their 200 DMAs", "summary": "", "url": "https://news.google.com/rss/articles/CBMi4AFBVV95cUxNb190R0NxNFZSeG5QWWF6VWpDMHM1NXUwVU9hazBMVkh6LTd4bEc5WndRdG43eUg2VkVtby1zUHg1V1BlQm5nMXJTbEZMYmgwcXE2c0tFTUJZaE4yOGJMdTAteENZbnlnY2ZwcjNpa1NKVlRidGxtNmlfQ2Q0N2dKX0tIYkNSUFZYT1Vyclg1c0xsRTBqdG54eWFQZjh2SmpIYUtJVjd0emZNVThHRjExSmFSTTVVQmVUUjYyb2JDV28yLXdiWnpNUlpjRDlpOFlFQWRQc1dhbzcxbFlfdi1FRg?oc=5", "source_name": "The Economic Times", "published_at": "2026-05-26T07:00:00+00:00", "published_display": "26 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Piramal Pharma Schedules Investor Meetings from 28 May", "summary": "", "url": "https://news.google.com/rss/articles/CBMi6AFBVV95cUxPQ1JjTk1uTVJRSEY3SGRvN25XWFUtLU5ocDBjOG9LTE50UWg3MUVHYkxYb2RrQkRDMHVDLTZhaDZ0UVdGVWdYckZqVkQwcl9NTnRvd2p4UGpLMnVsQkUxa3JWbVUxbUJwTjF5WU13cURNT21WY0dnbVJvc1BTajd3clNDVjlTbXNhWW5Ca1lfeU1iSGd4MVIzc20wM3hmaTdNU3JjMVpxNXlUZDZ1aElDS3BEUkRIanl3NTJGWGppRmdHbnpIQWhGU2F2djhMRUNPYlhfU29tWlAtUEJWZUU1RnZxZC1PcU1w?oc=5", "source_name": "scanx.trade", "published_at": "2026-05-19T07:00:00+00:00", "published_display": "19 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Piramal Pharma, Tanla & PTC India Surge in May After Being Picked by AI Strategy By Investing.com", "summary": "", "url": "https://news.google.com/rss/articles/CBMizwFBVV95cUxNUGU0UUoyYldKdzhRZHhlYkVaS0hfMHJkUmVaeEZOcjJNRkNoRXZheS1WdUdlUGFUd196VFR0N3B3UXBXTHMyZmhuN2dMWk9PNE1FM3ZBNUlwRTA2Zl9hNjhJQTBxRkZ4S2RqS1VYdEk2aXN2Y1RGYVRvenBNMXFjbG1WS1JWSERRb0o1eVd0WUNUY1dPb2prdE1TcUREY01hTjc5Rl9jQ2hLdXoyOW1wOC1zNWk0dUs5TmpMR1l1Z2FQZ25lV3VuWEpyNmxhdnc?oc=5", "source_name": "Investing.com India", "published_at": "2026-05-08T07:00:00+00:00", "published_display": "08 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Piramal Pharma Limited Announces Schedule of Analyst/Institutional Investor Meeting for May 27, 2026", "summary": "", "url": "https://news.google.com/rss/articles/CBMi1gFBVV95cUxNUkVSOEc5S1c3c2VvQVlvNnRpZDBDQ2g1NEI5WVc4WDdoSmVCSjRRZlEtN0dRbVNtYUVrYV9GdUswRUJYMDZjT0kzUDNrSjN0LUFxeldWTExaaXQydUp1RmJ6SktqeWo3OWRmaW8tN0lSLUU3UWNJOTlMTXlDcXhkSDBKaW5yTEdETXUwSFlqeG4tVUdFTVdKZDY1c194bGFfRHctR3Y0cGNvSFdCekp4Q04zUnRGemlGMW1rRnZCenA5Q2pRZmFZWXAxQVRuSlFLSWVZQ1JB?oc=5", "source_name": "scanx.trade", "published_at": "2026-05-04T07:00:00+00:00", "published_display": "04 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Nifty Pharma index rises 2.5% on strong growth prospects; Dr Reddy's, Piramal Pharma jump up to 11%", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "Moneycontrol.com", "published_at": "2026-04-23T07:00:00+00:00", "published_display": "23 Apr 2026 07:00", "sentiment": "positive", "sentiment_pct": 82, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Nifty Pharma index soars 3%; Dr Reddy's, Piramal Pharma rally up to 9%", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "Business Standard", "published_at": "2026-04-23T07:00:00+00:00", "published_display": "23 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Piramal Pharma Schedules Board Meeting and Earnings Call for Q4FY26 Results", "summary": "", "url": "https://news.google.com/rss/articles/CBMi7gFBVV95cUxNZkpBbnJWMVlRVjI5QTBBOTlVMTB5cWZDVkFoNXlaNEZqX0JMV3JVODVJcnlJaDY4bHlPN1JWZEdCdEtMOXRhUS1yekNjYzlRRnNLS194SzdVMlBjS3RfQ0dsR2NiTllEYTNLRkFUellndERJU3RJVTUyWVM2STgyRzJSdTR2djBUcVRjSGhhZnJtTnBUUHFHNlpKUWEwV0dzeV8yOHZlUWo0c0FWVWxyYnlJMlcxdG5pS3RITUhSTmpOTktUQ3Y0aEpIWGpiSE5IMWxWcm5xWFZkemhSVVgyMWZHaWxtZU9HWERtcXhB?oc=5", "source_name": "scanx.trade", "published_at": "2026-04-17T07:00:00+00:00", "published_display": "17 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Piramal Pharma Ltd spurts 2.13%, rises for third straight session", "summary": "", "url": "https://news.google.com/rss/articles/CBMi3gFBVV95cUxOTU5ScXRGMnRjVWJWSzlFOTl2UWpCRXVIajU5bnJVeDZEMzRNNXo2ZVpjdlBOZnF6dHk2bUhvRUpFT0pKN3J1Zk5WNmRrREJHc0hSWXNwcEh0WXh1THNKLXFtb2E2NkFCRHJuc1U2aTBGc24wTFB1Z1ZYUmNpaVRoU3VfTnVmR2NGdkpiNG80UEpSc19sM2RfWUhnLUVXTTg0b3FZVWZ0QkZsZ0h3VEI2c2xSelkzaUNvaGJadjg0RVhxcFh1eVVmOWgwRE5zenFZZklDeTdoTmhGa2J1bkHSAeMBQVVfeXFMUGczWjlwajk0WmluNkZuYnJTS3dxN1FKamw0cVRlUGxwQVE4VmhFQllMdjFxdHI2V0FHTWJDcmZZX1BJV3BtbnMzbXVoenotNmlRaXNrOEdNYmVPWk1iSGp6MVlHZ2RISEFNSWV4R3BvLVd3SjZSeHFSVG5UNEUzNThqR0lNSFpjZHI0X0dXMHdDN0hyNXp3VXlER1E3cDE4cGdGd0dVaHdXcGowZElWNFIzTS1la0VRdE1yVnhHRWQySW5LU1JBTnpRSVl0bEFMOWwySGF3LWlZSURfd1VCMjB4Tm8?oc=5", "source_name": "Business Standard", "published_at": "2026-04-15T07:00:00+00:00", "published_display": "15 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Trump tariffs hit patented drugs: Jefferies, Nomura explain impact on pharma stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMi7AFBVV95cUxOOURreGN5eDNZSERyb0tadW9lUnVMbk5yb01OZ3Q0WHBOLTVrRVVzRnNraWhzNVZmV0lRc0VmT3V1aHVsNFVPUDRnWl9MR2ZFSTFMS09KNW9BUzJwZ0ZvUUZxU1FXMnJZYWtHcmV1ZnpRa3ZXamNQZXhxalN4TTZoQ25nekFFM0lERnp3MkE4UVVjZzBMWTJuY01KcFpKWURnaUJoNV80dmlvVUNFQmc3THhjTG5Zbmt4VGc4MXlxVWxBbF9BQ1pSZ1Q0bnlyak5SSUFQWVNTUFdyUnJBNmVDVVpGY1JKTlNfRnBjbg?oc=5", "source_name": "ETPharma.com", "published_at": "2026-04-07T07:00:00+00:00", "published_display": "07 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Lupin, Biocon: Nifty Pharma gains 3% after US-India trade deal pact", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "Business Standard", "published_at": "2026-02-03T08:00:00+00:00", "published_display": "03 Feb 2026 08:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Piramal Pharma Limited (NSE:PPLPHARMA) Just Reported Earnings, And Analysts Cut Their Target Price", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-01-31T08:00:00+00:00", "published_display": "31 Jan 2026 08:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Piramal Pharma Releases Q3FY26 Earnings Call Transcript Following Results Discussion", "summary": "", "url": "https://news.google.com/rss/articles/CBMi3gFBVV95cUxQRlRCUzBxR0lFMDNCa3B3OFRHQW5LNVp6Mk5zMGlMa05mdWFWVm52MmgtLUN4ZmlPaDF0clRSeXNiUldXSmQ1b0hUMER5WVVONG54Z1R5eGRHenpMN1BNRUFOcHI2NVBIYjZLTEU2UnNGajlUMzQwVS1KREdQVzVuNG9LOHRsazVOMmdlV0cwTmF5QTBxMnhKU0xQcFRUSUljN3R1VXF4VFFZc0hGemZtbDA0QUk2bzhzdlItOXI0Nnd6OE1KczhxcVZjX1RBVWRHY3RaOERKNHM2YW5YbVE?oc=5", "source_name": "scanx.trade", "published_at": "2026-01-30T08:00:00+00:00", "published_display": "30 Jan 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Piramal Pharma shares gain 4% on Q3 results; check key highlights inside", "summary": "", "url": "https://news.google.com/rss/articles/CBMi2wFBVV95cUxOMVBlVGl0QkZRelRHbTF0ZC1hWTlUbVVkZ1ZSS0tHb0hwRzNfaG1DVHYycDhmOW10SmZKaEF1SW4xWmpCb2NlaWNZSjF2NDc1VGVSWGgzenRKQjNWbzZGOUlENGtIMEU2cFhMMjVOQllJeldRSGMxaHA1T0FlSFUwVmpiQmJjN0prZDhHbTNPTV9rM2RWRjNKWkF6UlFudXBOanF1MVlPY0NSWlZ3M3IzTlI3dUc0ZzljUW1CQV80VC1aNjlPeDJfUzM1Q2xKYjJ0XzNxXzdmd29ULUHSAeABQVVfeXFMUC1rejVORHRkYUN4S3E5TzVuRDVxMDZ0MDlDcUp6WlNxVXRobU93NTlyaEtyeVd3NGdxNnZhNDVZRGFGLTl1azNwV0x2X3FSX2V1ZDJ6NEtkY1ZWblc5NFRDSDRySk5OU2tSOUtoYzViNUU4VjdTT2RDYmVtalJHQU42dnQteGtER1RRSmFnNWF0U3gyR0J1SC1lODRxVm9nU2xMMWhjZG5sWW9CRUhsSFVYai1GbEdOcU9SU1VIZHJVeE54aTZiOWtaSXl2cS16bEp4aWZZZUdzZ1VXLTVrYjg?oc=5", "source_name": "Business Standard", "published_at": "2026-01-29T08:00:00+00:00", "published_display": "29 Jan 2026 08:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Buy, Sell or Hold: Piramal Pharma Ltd, Kaynes Technology India Ltd, Electronics Mart \u2014 Ask Profit", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "NDTV Profit", "published_at": "2026-01-22T08:00:00+00:00", "published_display": "22 Jan 2026 08:00", "sentiment": "positive", "sentiment_pct": 74, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Piramal Pharma (NSE:PPLPHARMA) Takes On Some Risk With Its Use Of Debt", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-01-15T08:00:00+00:00", "published_display": "15 Jan 2026 08:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Piramal Pharma Ltd. Share Price Today - Piramal Pharma Ltd. Stock Price Live NSE/BSE", "summary": "", "url": "https://news.google.com/rss/articles/CBMigAFBVV95cUxOUXVHS3NYLWU4b2ZzYU1XMlNlbFpmd0xfMHFfU1hBRDFsVjZObjFUb0xCc0wzejRTd2RoSV84M1RxLVFpYlRVcXJRMEo5LTRMTUo1dnhTOFd2anJsZDFGZVFXdGQ5UHoxdHNOUWR6SXpBUHZ2djJfZkd1bmVya0Y5Nw?oc=5", "source_name": "CNBC TV18", "published_at": "2026-01-03T16:33:11+00:00", "published_display": "03 Jan 2026 16:33", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Stocks to Watch Today: Vedanta, Piramal Pharma, NBCC, Cyient, Honasa Consumer, Kansai Nerolac,...", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "Moneycontrol.com", "published_at": "2025-12-12T08:00:00+00:00", "published_display": "12 Dec 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Corner Office Conversation: Nandini Piramal of Piramal Pharma & Arjun Juneja of Mankind Pharma", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "The Economic Times", "published_at": "2025-11-24T08:00:00+00:00", "published_display": "24 Nov 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "The Price Is Right For Piramal Pharma Limited (NSE:PPLPHARMA)", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2025-11-06T08:00:00+00:00", "published_display": "06 Nov 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Piramal Pharma Q2 Loss \u20b999 Cr as Revenue Falls 9% YoY", "summary": "", "url": "https://news.google.com/rss/articles/CBMif0FVX3lxTE5JVUo4LTVNczVURjFoYmhQOWozanpXaXZjUUQzS2RLYVN1YTFRNWJ4NFVwNEtLRk9KVVJxeHFYTUhuMmQxTU54S1l4NHVkc0hIWlVyZ3YxV0tJTXJhNGR0RGxneDNFQzBER0hrOWVlYURDMFZacF90NS15WmdkMzQ?oc=5", "source_name": "HDFC Sky", "published_at": "2025-11-06T08:00:00+00:00", "published_display": "06 Nov 2025 08:00", "sentiment": "negative", "sentiment_pct": 18, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Piramal Pharma Reports 21% Revenue Decline in Q2FY26, Cites Customer Inventory Destocking", "summary": "", "url": "https://news.google.com/rss/articles/CBMi2wFBVV95cUxNeFVLVlBiMmhfZEhWVkJ5WFJLYnVaeHRIN0VGWkNnRGhhVVhUQ1ZHdW9ZcGJqTFBncU1pRHZLMXVwUWFCQ283bWowbnlMYjN5MHNxU1RPdDRpV1NNa1c4ZDFqc09kYUxNZThtNTNqLTdlUlZFWVhGanJHOVc1dHpYMzY3blhlSlhsaXlpT3Vkakg3WjJKbVV0dmdlcjd3ZmFHSlloakFsU3hrRHlDR1FoSlBnY1BVb0lsYXRvSzZ1T3hDbDg4d2swRGJRUFRxbEVyXy1HekRiRmdmNms?oc=5", "source_name": "scanx.trade", "published_at": "2025-11-05T08:00:00+00:00", "published_display": "05 Nov 2025 08:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Are Piramal Pharma Limited's (NSE:PPLPHARMA) Mixed Financials Driving The Negative Sentiment?", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2025-10-07T07:00:00+00:00", "published_display": "07 Oct 2025 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "InCred Equities sees 41% upside in Piramal Pharma; initiates 'Buy'", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "Business Standard", "published_at": "2025-09-26T07:00:00+00:00", "published_display": "26 Sep 2025 07:00", "sentiment": "positive", "sentiment_pct": 82, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Piramal Pharma Subsidiary Invests $190.3 Million in PPL Pharma Inc.", "summary": "", "url": "https://news.google.com/rss/articles/CBMiygFBVV95cUxPb0h5MnNHOUFoOWZwSzk2MzJITnBQTGpqcjFoaV9VbTh3eWI2YTlpWHNkN1M2ZDVlcWJ6aEVkUk5MSkFoVEI1WXpoemxlbldrTUU3X2F4M2R4blItUWpoS21VRzM5b0h0SUdkVmxzdzdDMUs1RXZVVko2OGFObTR3dV83Y0kxWTVwc3hNeURjX2FaSm9NWXA5UG5ELUF2TmZYOXVDazJ5VWVzbERvbl92cko1Q0xRdGtfSFpoQTFvQjFiTVpzWTE3WjBR?oc=5", "source_name": "scanx.trade", "published_at": "2025-08-20T07:00:00+00:00", "published_display": "20 Aug 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Piramal Pharma unit infuses \u20b91,626 crore into PPL Pharma via preference shares", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "CNBC TV18", "published_at": "2025-08-20T07:00:00+00:00", "published_display": "20 Aug 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Piramal Pharma Ltd Share Price Today \u2013 Live NSE/BSE", "summary": "", "url": "https://news.google.com/rss/articles/CBMib0FVX3lxTE5QdkNRaDdFNVcwcEhHSWMycjNxR3BfbkhOTzZGR2RJM2R6MU9Qb1RTckRuaWtJYVNNdDBaMUxlMndvLVVxYzhLcC1FSGd2ZlVjRnI2SVNheEM3MGFDNzVQOS1wZEs1QUc3UDljcVM2cw?oc=5", "source_name": "INDmoney", "published_at": "2023-02-23T21:59:50+00:00", "published_display": "23 Feb 2023 21:59", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Technical Analysis of Piramal Pharma Limited (NSE:PPLPHARMA)", "summary": "", "url": "https://news.google.com/rss/articles/CBMibkFVX3lxTE8xT1hFSVJ4VzJZaGJrUjhmU2NsUkttX1I4cWxPeHVacmdLUFRMdUlIaFlYVEZvUWJod0wtb2QxMlN3ZUVueFhvbUtHSktKQmgxQ0JPY0tZY0tFcFpiY0ZUNXdrR2I2RGRMS0I3dDVB?oc=5", "source_name": "TradingView", "published_at": "2022-10-19T19:28:39+00:00", "published_display": "19 Oct 2022 19:28", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Piramal Pharma Limited lists on BSE and NSE", "summary": "", "url": "https://news.google.com/rss/articles/CBMipAFBVV95cUxPVjRHbWVuUS11MkQxdkhlckh6Wk1QVmNNaktjdmMxVS1fc3BYQUtYdE0zYzRPeEdHS054VV9xVWhjc2swNHdna25BNlZNekxCZEI5V1NUYkptQzJBbGlScjJFUzZKQktDcnlOSERzclQwTl9KV0lKdzYyQmhGM2o1MXpxcGU5NUFxN1Z6eDZjcGdidjYtTmxwVE5ZUktmajhYbmVLYw?oc=5", "source_name": "PR Newswire", "published_at": "2022-10-19T07:00:00+00:00", "published_display": "19 Oct 2022 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 74, "total_relevant": 34, "sentiment_summary": {"positive": 10, "negative": 5, "neutral": 19, "score": 55, "total": 34, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 86, "events": [{"event": "general", "label": "Market update", "weight": 17.75, "count": 24}, {"event": "earnings", "label": "Earnings", "weight": 4.55, "count": 7}, {"event": "deals", "label": "Deals and strategy", "weight": 0.9, "count": 1}, {"event": "analyst", "label": "Analyst action", "weight": 0.55, "count": 1}, {"event": "liquidity", "label": "Balance sheet", "weight": 0.55, "count": 1}], "positive_events": 10, "negative_events": 5}, "market_context": {"has_market_context": true, "latest_close": 177.16, "latest_week": "2026-07-10", "one_week_move": 0.7, "four_week_move": 8.1, "twelve_week_move": 19.0, "trend_signal": "1", "trend_label": "Trend active", "trend_tone": "positive", "market_dynamics": 1.075837, "market_dynamics_buy_signal": false, "relative_strength": 3.349802, "fair_value_gap": 2.0, "fair_value_label": "Near fair-value range", "fair_value_tone": "neutral", "expectation_direction": "undecided", "expectation_probability": 53.2402, "reaction_label": "Price digesting", "reaction_tone": "neutral", "market_sentence": "+0.7% over one week, +8.1% over four weeks, trend active, and near fair-value range."}, "interpretation": {"label": "Balanced read", "tone": "neutral", "classification": "balanced", "summary": "News tone and price action are not far from neutral.", "confidence": 56, "badges": [], "opportunities": [], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "Business Standard", "count": 8}, {"label": "scanx.trade", "count": 7}, {"label": "simplywall.st", "count": 4}, {"label": "NDTV Profit", "count": 2}, {"label": "The Economic Times", "count": 2}, {"label": "Moneycontrol.com", "count": 2}, {"label": "CNBC TV18", "count": 2}, {"label": "Equitymaster", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 34}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 24}, {"label": "Earnings", "count": 7}, {"label": "Analyst action", "count": 1}, {"label": "Deals and strategy", "count": 1}, {"label": "Balance sheet", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "55/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Balanced read", "tone": "neutral", "text": "News tone and price action are not far from neutral."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "86/100 classification confidence."}, {"label": "Company focus", "value": "34", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "16", "tone": "positive", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend active", "tone": "positive", "text": "+0.7% over one week, +8.1% over four weeks, trend active, and near fair-value range."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "Piramal Pharma shares rise 4% on successful closure of US FDA inspection"}], "updated_at": "2026-07-17T06:46:58.461517+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}